MYL2 and colitis: CerS2 null mice exhibited severe colitis upon DSS treatment, along with increased intestinal permeability, higher myosin light chain 2 (MLC2) phosphorylation and diminished levels of junctional adhesion molecule‐A (JAM‐A) in the colon.